Abstract

BackgroundEvaluating the cost-effectiveness of breast cancer screening requires estimates of the absolute risk of breast cancer, which is modified by various risk factors. Breast cancer incidence, and thus mortality, is altered by the occurrence of competing events. More accurate estimates of competing risks should improve the estimation of absolute risk of breast cancer and benefit from breast cancer screening, leading to more effective preventive, diagnostic, and treatment policies. We have previously described the effect of breast cancer risk factors on breast cancer incidence in the presence of competing risks. In this study, we investigate the association of the same risk factors with mortality as a competing event with breast cancer incidence.MethodsWe use data from the Canadian National Breast Screening Study, consisting of two randomized controlled trials, which included data on 39 risk factors for breast cancer. The participants were followed up for the incidence of breast cancer and mortality due to breast cancer and other causes. We stratified all-cause mortality into death from other types of cancer and death from non-cancer causes. We conducted separate analyses for cause-specific mortalities.ResultsWe found that “age at entry” is a significant factor for all-cause mortality, and cancer-specific and non-cancer mortality. “Menstruation length” and “number of live births” are significant factors for all-cause mortality, and cancer-specific mortality. “Ever noted lumps in right/left breasts” is a factor associated with all-cause mortality, and non-cancer mortality.ConclusionsFor proper estimation of absolute risk of the main event of interest common risk factors associated with competing events should be identified and considered.

Highlights

  • Evaluating the cost-effectiveness of breast cancer screening requires estimates of the absolute risk of breast cancer, which is modified by various risk factors

  • The risk of breast cancer incidence is always higher than the risk of all-cause mortality for younger women (40–49) within the follow-up period

  • For older women (50–59), breast cancer incidence is lower than the risk of death in about the first six years of follow-up; the curves for breast cancer incidence and all-cause mortality cross at this point and the probability of death is higher than breast cancer incidence subsequently

Read more

Summary

Introduction

Evaluating the cost-effectiveness of breast cancer screening requires estimates of the absolute risk of breast cancer, which is modified by various risk factors. Mortality, is altered by the occurrence of competing events. We have previously described the effect of breast cancer risk factors on breast cancer incidence in the presence of competing risks. We investigate the association of the same risk factors with mortality as a competing event with breast cancer incidence. Mell et al [3] identified predictors of non-cancer causes of death in head and neck cancer and developed a risk stratification model for these competing events. Mell et al [4] used competing risk modeling to identify predictors of non-cancer mortality in women with early breast cancer, while considering disease recurrences as competing risks

Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call